Asia
The investigation dates back to a probe launched in May by Israel’s version of the U.S. SEC though the subject matter of the investigation was not initially revealed.
The results demonstrate that the combination of BL-8040 with HiDAC in this difficult-to-treat patient population significantly improved overall survival, compared with historical data of HiDAC monotherapy.
12 Sigma Technologies, a San Diego medical imaging firm founded by a team of Chinese scientists, raised $30M in a B round led by China VC firm SBCVC.
Although GenomiCare did not disclose the size of the A round, the company did say it has raised $25M since its inception in 2015.
Shares of Ultragenyx are sharply climbing this morning after the company announced positive results from its Phase III study of burosumab in adults with XLH.
Sanofi said the analysis showed more cases of severe disease could occur following vaccination in patients who had not been previously infected by the dengue virus.
Zhenxing Biopharma raised $322M by selling a 19% share of the company to Kaisa Group Holdings.
Astellas is pulling the trigger on an acquisition option from a partnership deal the two companies formed in 2013.
Gilead priced its Sovaldi treatment for hepatitis C at $8,938 in China - about one-fifth the current price in the U.S.
On Wednesday, KBR reported that a male employee at Novartis Korea reported to the company that his female boss sexually harassed him in September.
PRESS RELEASES